查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲基因檢測服務市場預測至 2030 年 - 區域分析 - 按服務類型、疾病和服務提供者
市場調查報告書
商品編碼
1533074

歐洲基因檢測服務市場預測至 2030 年 - 區域分析 - 按服務類型、疾病和服務提供者

Europe Genetic Testing Services Market Forecast to 2030 - Regional Analysis - by Service Type, Disease, and Service Provider
出版日期: | 出版商: The Insight Partners | 英文 108 Pages | 訂單完成後即時交付

價格

2022年歐洲基因檢測服務市值9.3111億美元，預計2030年將達27.7842億美元；預計2022年至2030年複合年成長率為14.6%。

對個人化藥物的認知和接受度不斷提高推動歐洲基因檢測服務市場

個人化醫療是利用患者的遺傳和環境資料提供最佳醫療保健的領域。它基於每個患者都是獨特的並且需要個別化藥物治療的原則。由於它是一個快速發展的領域，目前已納入多個醫療保健系統。 2003年人類基因組計畫（HGP）的成功完成以及人類基因組定序成本的快速下降鼓勵了一種新的醫療方法的發展，即個人化醫療。隨著分子層級個人化資料儲存庫的不斷擴大，分子診斷公司在釋放價值方面處於特殊地位。大規模藥物發現是提高個人化藥物在疾病和病症診斷的可行性和有用性的關鍵。基因組學是醫學科學中發展最快的部門之一。它正在推動疾病研究方法以及疾病診斷和治療的範式轉移。基因檢測已廣泛應用於藥物基因組學，也稱為藥物基因檢測。它有助於加速藥物發現及其開發。法國也制定了一項名為「法國基因組醫學 2025」的個人化醫療國家計畫。 2016 年6 月，阿維桑國家生命與健康科學聯盟主席兼Inserm 首席執行官伊夫·利維(Yves Levy) 向總理曼努埃爾·瓦爾斯(Manuel Valls) 提交了該計劃。保健和製造公司試點基因組定序平台。該計劃得到了政府的支持，並於 2020 年啟動了 7.608 億美元（6.7 億歐元）的公共融資，用於基因組學和個性化醫療項目。預計未來十年內法國將成為基因組醫學領域的領先國家。 2023 年 1 月，人類基因組計畫將開啟個人化醫療保健時代。現在，新的研究表明，使用基因檢測進行精確處方最終已達到全球採用的臨界點。這項經過同行評審的研究由劍橋大學出版社出版，研究了大規模使用臨床遺傳學所需的關鍵因素的成熟度。這些進步為支持將基於基因組的臨床決策建立為新的護理標準鋪平了道路。基因知情處方提供了成功降低醫療保健系統總體成本和改善個別患者護理的現實機制之一。基因檢測透過了解疾病背後的科學、治療的影響以及針對特定個體特徵的療法的開發，鼓勵採用個人化醫療方法。它還可以幫助醫護人員利用基因檢測結果做出有關疾病診斷、治療和預防的明智決策，從而改善患者的治療結果。

歐洲基因檢測服務市場概況

歐洲基因檢測服務市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。基因檢測一直以驚人的速度成長。現在提供大量測試來篩檢多種遺傳疾病。許多罕見遺傳疾病都有治療方法，而且這個過程在攜帶者檢測、新生兒篩檢、預測性和症狀前檢測等場景中變得越來越重要。此外，歐洲國家也採取了一系列措施來提高人們對基因檢測益處的認知。最終目標是確保基因檢測的各個方面都是高品質的，從而提供準確可靠的結果，造福患者。

歐洲基因檢測服務市場收入及 2030 年預測（百萬美元）

歐洲基因檢測服務市場細分

歐洲基因檢測服務市場按服務類型、疾病、服務提供者和國家分類。

根據服務類型，歐洲基因檢測服務市場可細分為預測檢測、帶因者檢測、產前檢測、新生兒篩檢等。預測測試領域在 2022 年佔據最大的市場佔有率。

從疾病類型來看，歐洲基因檢測服務市場分為癌症、代謝疾病、心血管疾病和其他疾病。 2022 年，癌症細分市場佔據最大的市場。

依服務提供者分類，歐洲基因檢測服務市場分為醫院實驗室、診斷實驗室等。 2022 年，醫院實驗室細分市場佔據最大市場佔有率。

依國家/地區分類，歐洲基因檢測服務市場分為英國、德國、法國、西班牙、義大利和歐洲其他地區。 2022年，德國在歐洲基因檢測服務市場佔有率中佔據主導地位。

Eurofins Scientific SE、Exact Sciences Corp、Laboratory Corp of America Holdings、23andMe Holding Co、Quest Diagnostics Inc、Illumina Inc、F. Hoffmann-La Roche Ltd、NeoGenomics Inc 和 Centogene AG 是歐洲基因檢測領域的領先公司之一服務市場。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：歐洲基因檢測服務市場 - 主要產業動態

  • 主要市場促進因素
    • 遺傳性疾病盛行率上升
    • 提高對個人化藥物的認知和接受度
    • 對直接面對消費者 (DTC) 的基因檢測的偏好日益成長
  • 市場限制
    • 基因檢測的社會和倫理影響
    • 遺傳服務的承受能力
  • 市場機會
    • 對藥物基因組學的需求不斷成長
  • 未來趨勢
    • 人工智慧驅動的基因檢測
  • 影響分析：

第 5 章：基因檢測服務市場 - 歐洲市場分析

  • 歐洲基因檢測服務市場收入，2022 - 2030

第 6 章：歐洲基因檢測服務市場 - 收入和 2030 年預測 - 按服務類型

  • 概述
  • 2022 年及 2030 年歐洲基因檢測服務市場收入佔有率，依服務類型分類 (%)
  • 預測測試
  • 營運商測試
  • 產前檢測
  • 新生兒篩檢
  • 其他

第 7 章：歐洲基因檢測服務市場 - 收入和 2030 年預測 - 按疾病分類

  • 概述
  • 2022 年及 2030 年歐洲基因檢測服務市場收入佔有率（按疾病分類）（%）
  • 癌症
  • 心血管疾病
  • 代謝性疾病
  • 其他疾病

第 8 章：歐洲基因檢測服務市場 - 收入和 2030 年預測 - 按服務提供者

  • 概述
  • 2022 年和 2030 年歐洲基因檢測服務市場收入佔有率（按服務提供者分類）（%）
  • 醫院實驗室
  • 診斷實驗室
  • 其他

第 9 章：歐洲基因檢測服務市場 - 國家分析

  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區

第 10 章：基因檢測服務市場-產業格局

  • 概述
  • 基因檢測服務市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 11 章：公司簡介

  • Eurofins Scientific SE
  • Exact Sciences Corp
  • Laboratory Corp of America Holdings
  • 23andMe Holding Co
  • Quest Diagnostics Inc
  • Illumina Inc
  • F. Hoffmann-La Roche Ltd
  • NeoGenomics Inc
  • Centogene AG

第 12 章：附錄

Product Code: TIPRE00009240

The Europe genetic testing services market was valued at US$ 931.11 million in 2022 and is expected to reach US$ 2,778.42 million by 2030; it is estimated to register a CAGR of 14.6% from 2022 to 2030.

Increasing Awareness and Acceptance of Personalized Medicines Drive Europe Genetic Testing Services Market

Personalized medicine is the field that utilizes patients' genetic and environmental data to deliver optimal healthcare. It is based on the principle that every patient is unique and requires individualistic pharmacological treatment. Since it is a rapidly evolving area, it is presently incorporated into several healthcare systems. The successful completion of the Human Genome Project (HGP) in 2003 and the fast-decreasing human genome sequencing costs encouraged the development of a new medical approach, which is called personalized medicine. With an expanding repository of personalized data at the molecular level, molecular diagnostics companies are exceptionally positioned to unlock value. Large-scale drug discovery is a key to increasing the viability and usefulness of personalized medicines for the diagnosis of diseases and disorders. Genomics is one of the fastest-growing divisions of medical science. It is driving a paradigm shift in the research methodology of a disease, as well as diagnosing and treating illness. Genetic testing has been extensively used in pharmacogenomics, also known as drug-gene testing. It helps in accelerating drug discovery and its development. France also developed a national plan for personalized medicine known as "Genomic Medicine France 2025." The program was presented to Prime Minister Manuel Valls by Yves Levy, President of the National Alliance for Life and Health Sciences-Aviesan and CEO of Inserm, in June 2016. It appeals to healthcare and manufacturing firms to pilot genomic sequencing platforms. The plan was supported by the government and launched with a public financing of US$ 760.8 million (€670 million) in 2020 for genomics and personalized medicine programs. It is expected to place France as a leader among countries involved in genomic medicine within the next ten years. In January 2023, The Human Genome Project is ensuring an era of personalized healthcare. Now, new research shows that precision prescribing using genetic testing has ultimately reached a global tipping point for adoption. Published by Cambridge University Press, the peer-reviewed research examines the maturation of critical factors required for the use of clinical genetics at scale. These advancements pave the way for supporting genome-informed clinical decision-making to be established as the new standard of care. Genetically informed prescribing offers one of the realistic mechanisms to successfully reduce the overall costs of the healthcare system and improve individual patient care. Genetic testing encourages the adoption of a personalized medicine approach by understanding the science behind the disease, the impact of treatment, and the development of therapies for specific individual characteristics. It also helps healthcare personnel make informed decisions about disease diagnosis, treatment, and prevention by utilizing genetic testing results, leading to improved patient outcomes.

Europe Genetic Testing Services Market Overview

European genetic testing services market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Genetic testing has been growing at an exceptional rate; a large panel of tests are now offered to screen a number of genetic diseases. Treatments are available for a number of rare genetic diseases, and the process is gaining importance in scenarios such as carrier testing, newborn screening, and predictive and pre-symptomatic testing, among others. Moreover, European countries have undertaken a number of initiatives to increase awareness among people about the benefits of genetic testing. The ultimate goal is to ensure that all aspects of genetic testing are of high quality, thereby providing accurate and reliable results for the benefit of the patients.

Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Million)

Europe Genetic Testing Services Market Segmentation

The Europe genetic testing services market is categorized into service type, disease, service provider, and country.

Based on service type, the Europe genetic testing services market is segmented predictive testing, carrier testing, prenatal testing, newborn screening, and others. The predictive testing segment held the largest market share in 2022.

In terms of disease, the Europe genetic testing services market is categorized into cancer, metabolic diseases, cardiovascular diseases, and other diseases. The cancer segment held the largest market share in 2022.

By service provider, the Europe genetic testing services market is segmented into hospital-based laboratories, diagnostic laboratories, and others. The hospital-based laboratories segment held the largest market share in 2022.

By country, the Europe genetic testing services market is segmented into the UK, Germany, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe genetic testing services market share in 2022.

Eurofins Scientific SE, Exact Sciences Corp, Laboratory Corp of America Holdings, 23andMe Holding Co, Quest Diagnostics Inc, Illumina Inc, F. Hoffmann-La Roche Ltd, NeoGenomics Inc, and Centogene AG are among the leading companies operating in the Europe genetic testing services market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Genetic Testing Services Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Rising Prevalence of Genetic Diseases
    • 4.1.2 Increasing Awareness and Acceptance of Personalized Medicines
    • 4.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
  • 4.2 Market Restraints
    • 4.2.1 Social and Ethical Implications of Genetic Testing
    • 4.2.2 Affordability of Genetic Services
  • 4.3 Market Opportunities
    • 4.3.1 Rising Demand for Pharmacogenomics
  • 4.4 Future Trends
    • 4.4.1 Artificial Intelligence-Powered Genetic Testing
  • 4.5 Impact Analysis:

5. Genetic Testing Services Market - Europe Market Analysis

  • 5.1 Europe Genetic Testing Services Market Revenue (US$ Mn), 2022 - 2030

6. Europe Genetic Testing Services Market - Revenue and Forecast to 2030 - by Service Type

  • 6.1 Overview
  • 6.2 Europe Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
  • 6.3 Predictive Testing
    • 6.3.1 Overview
    • 6.3.2 Predictive Testing: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Carrier Testing
    • 6.4.1 Overview
    • 6.4.2 Carrier Testing: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Prenatal Testing
    • 6.5.1 Overview
    • 6.5.2 Prenatal Testing: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Newborn Screening
    • 6.6.1 Overview
    • 6.6.2 Newborn Screening: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.7 Others
    • 6.7.1 Overview
    • 6.7.2 Others: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Genetic Testing Services Market - Revenue and Forecast to 2030 - by Disease

  • 7.1 Overview
  • 7.2 Europe Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
  • 7.3 Cancer
    • 7.3.1 Overview
    • 7.3.2 Cancer: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Cardiovascular Diseases
    • 7.4.1 Overview
    • 7.4.2 Cardiovascular Diseases: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Metabolic Diseases
    • 7.5.1 Overview
    • 7.5.2 Metabolic Diseases: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Other Diseases
    • 7.6.1 Overview
    • 7.6.2 Other Diseases: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Genetic Testing Services Market - Revenue and Forecast to 2030 - by Service Provider

  • 8.1 Overview
  • 8.2 Europe Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
  • 8.3 Hospital-Based Laboratories
    • 8.3.1 Overview
    • 8.3.2 Hospital-Based Laboratories: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Diagnostic Laboratories
    • 8.4.1 Overview
    • 8.4.2 Diagnostic Laboratories: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Genetic Testing Services Market - Country Analysis

  • 9.1 Europe
    • 9.1.1 Europe Genetic Testing Services Market, by Country
      • 9.1.1.1 UK
        • 9.1.1.1.1 Overview
        • 9.1.1.1.2 UK Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.1.3 UK Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 9.1.1.1.4 UK Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 9.1.1.1.5 UK Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 9.1.1.2 Germany
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 Germany: Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.2.3 Germany: Europe Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 9.1.1.2.4 Germany: Europe Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 9.1.1.2.5 Germany: Europe Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 9.1.1.3 France
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 France Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.3.3 France Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 9.1.1.3.4 France Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 9.1.1.3.5 France Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 9.1.1.4 Italy
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 Italy Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.4.3 Italy Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 9.1.1.4.4 Italy Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 9.1.1.4.5 Italy Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 9.1.1.5 Spain
        • 9.1.1.5.1 Overview
        • 9.1.1.5.2 Spain Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.5.3 Spain Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 9.1.1.5.4 Spain Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 9.1.1.5.5 Spain Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 9.1.1.6 Rest of Europe
        • 9.1.1.6.1 Overview
        • 9.1.1.6.2 Rest of Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.6.3 Rest of Europe Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 9.1.1.6.4 Rest of Europe Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 9.1.1.6.5 Rest of Europe Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)

10. Genetic Testing Services Market-Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in Genetic Testing Services Market
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Inorganic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Eurofins Scientific SE
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Exact Sciences Corp
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Laboratory Corp of America Holdings
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 23andMe Holding Co
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Quest Diagnostics Inc
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Illumina Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 F. Hoffmann-La Roche Ltd
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 NeoGenomics Inc
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Centogene AG
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Genetic Testing Services Market Segmentation
  • Table 2. UK Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. UK Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. UK Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Germany: Europe Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Germany: Europe Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Germany: Europe Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. France Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. France Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. France Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Italy Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Italy Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Italy Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Spain Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Spain Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Spain Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Rest of Europe Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Rest of Europe Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Rest of Europe Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Recent Organic Growth Strategies in Genetic Testing Services Market
  • Table 21. Recent Inorganic Growth Strategies in the Genetic Testing Services Market
  • Table 22. Glossary of Terms, Genetic Testing Services Market

List Of Figures

  • Figure 1. Europe Genetic Testing Services Market Segmentation, By Country
  • Figure 2. Europe Genetic Testing Services Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Genetic Testing Services Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Europe Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
  • Figure 6. Predictive Testing: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Carrier Testing: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Prenatal Testing: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Newborn Screening: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Others: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Europe Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
  • Figure 12. Cancer: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Cardiovascular Diseases: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Metabolic Diseases: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Other Diseases: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Europe Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
  • Figure 17. Hospital-Based Laboratories: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Diagnostic Laboratories: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: Europe Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Europe Genetic Testing Services Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 21. Europe Genetic Testing Services Market, By Key Countries, 2022 and 2030 (%)
  • Figure 22. UK Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 23. Germany: Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. France Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Italy Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Spain Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Rest of Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Growth Strategies in Genetic Testing Services Market